Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
about
Hypothalamus as an endocrine organ. IIInhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogsSomatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.An electroencephalographic investigation of short-term effects of three hypothalamic hormones (TRH, LH/FSH-RH, GH-RIH) in normal subjectsRelationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetesPancreatic immunoreactive somatostatin releaseBiosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.Evaluation of growth hormone secretion and treatment.Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Somatostatin: an endogenous peptide in the toad urinary bladder inhibits vasopressin-stimulated water flowEvidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogsGlucagon metabolism in the rat.Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.Prolonged serum insulin decreasing effects of two synthetic somatostatin analogues studied in vivo by a new animal method. Preliminary communication.The New Biology and Pharmacology of Glucagon.Gut endocrinology: correlation of physiology and morphology.Inhibition by somatostatin of glucose induced 3':5'-monophsophate (cyclic AMP) accumulation and insulin release in isolated pancreatic islets of the rat.Inhibition of H+ secretion in frog gastric mucosa by somatostatin.Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitusInhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.Sensitive radioimmunoassay for somatostatin using N-[125I]-Tyr-somatostatin as labelled antigen.Insulin disappearance rate in pregnant and non-pregnant women, and in non-pregnant women given GHRIH.Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.The hypothalamo-pancreatic axis: evidence for a neurohormonal pathway in the control of the release of insulin and glucagon.An in vivo model for testing somatostatin suppression of growth hormone release in sheep.Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose.Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.Hypersecretion of glucagon and gastrin in severely burnt patients.Growth hormone release inhibiting hormone: actions on thyrotrophin and prolactin secretion after thyrotrophinreleasing hormone.
P2860
Q24673295-8E752473-35F0-4DE7-A768-8DF17A0DE9F0Q34108250-C2278132-C2C6-4CFA-9106-FF3EE88AB05DQ34470821-8D3CFE71-77D7-41A8-86CD-2D2BA7770D50Q34476572-026125C2-D53B-49FC-9A70-59DBFE245B1DQ34515314-6AB83E94-15EB-46A3-9151-CC198C2774B0Q34553352-D2BDC95C-CC23-4678-8874-400B31B480C3Q34998597-CF643FC0-8254-47F9-97D2-3FBE563FAD44Q35028312-2E9CD0DB-82A1-4121-AA40-DBCAEEF08CB5Q35196738-C1A41876-B282-4F50-80B2-D6FD9520A1A9Q35199534-5EC7975D-5917-4946-9241-E980862AAAD0Q35354287-21E91D34-7CD1-4A7C-8D70-702CC42B81C8Q36245969-B4700278-66B6-4E6B-91D0-359DFC135BA8Q36403899-5D7EF50C-E373-4456-9F5D-FC69AE33B619Q37028092-BCE81D3E-791F-4238-A337-B358B944FF51Q37029361-16F1DFAA-F243-4BDE-88C9-E303D3E99BD6Q37031234-B6363F61-19FD-4BFD-B442-3BCC0975D5B7Q38358402-6D54A556-5500-49C3-B3DC-74797120DE27Q38919742-720C0D10-221A-425B-AD61-3F9B9CC670EDQ39510463-3717C8C1-5CAB-4DE6-8FF7-07099CFB8039Q39937045-874D5AB1-D439-45A0-BF37-92124F660D2AQ40228276-D0E1003A-F886-4D23-AB20-C57ED2DE7FD9Q40528874-7397A9C8-0E19-4F32-900F-4B6FD7328338Q40691311-3C5F60C8-44B0-4A9B-ABFF-68659255185FQ40888962-3F0FACF8-CE46-488C-A05F-5F94EE314610Q41032149-0E8BBC4B-AEF2-4536-8366-941C61F32021Q41228686-6DDEB550-679F-4742-96A5-7F0C51ECE300Q41344408-7C7CE838-F713-4BFF-9F7A-663E4DE9D24EQ42447340-19EF4238-27CE-403A-B0C8-047FE54F1AB6Q48482939-CE287822-AF03-4BDB-91CE-F4E8C6204451Q51658681-08B196E6-90FF-4851-8F9C-BC6877E5FDACQ52431482-9D256093-8E42-46EA-8D37-07488864B6BEQ54988358-9B24DE17-6D6A-47AC-8A7B-CA56752AE128Q55426463-73473D79-CF9B-415D-81AE-942D547C4C5CQ55646621-AEBE4721-6F13-4A85-86C2-91B1FD0FCA9F
P2860
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@en
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@nl
type
label
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@en
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@nl
prefLabel
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@en
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@nl
P2093
P1433
P1476
Effects of growth-hormone rele ...... c, and hypopituitary patients.
@en
P2093
A V Schally
C H Mortimer
C N Mallinson
G M Besser
P304
P356
10.1016/S0140-6736(74)92903-1
P407
P577
1974-04-01T00:00:00Z